Synthetic cathinone poisoning from ingestion of drug-laced “instant coffee packets” in Taiwan

Background: Synthetic cathinone abuse is a global health issue. Synthetic cathinones emerged in Taiwan in 2009, and their prevalence rapidly rose. They are usually made into “instant coffee packets,” and these so-called “toxic coffee packets” may also contain psychoactive drugs other than synthetic cathinones. Due to the diversity of the ingredients, clinical presentations can be complex. Methods: Retrospective analysis of emergency department (ED) patients who reported ingesting toxic coffee packets at three Chang-Gung Memorial Hospitals located in northern Taiwan between January, 2015 and December, 2019. Results: Sixty patients were included. Their mean age was 28.85 ± 9.24 years and 47(78.33%) were male. The most common presentations were palpitation, agitation, hallucination, and altered consciousness. Tachycardia and hypertension were common, while hyperthermia was observed in only three patients. Three patients (5%) developed rhabdomyolysis, and one underwent transient hemodialysis. Most patients were discharged from the ED, but 15(25%) were admitted, of whom nine (15%) were admitted to the intensive care unit (ICU), and one eventually died. Confirmation tests (mass-spectrometry-based analysis) were available in 10 patients; all reported positive for at least one type of synthetic cathinone. Polysubstance exposure was common. In multivariate logistic regression analyses, Glasgow coma scale ≤13 and the presence of seizure were associated with ICU admission. Conclusion: Patients who report ingesting toxic coffee packets are very likely to have been exposed to synthetic cathinones. Polysubstance exposure is common following ingestion. Cardiovascular and neurological symptoms are the main presentations, and severe complications such as rhabdomyolysis and life-threatening dysrhythmia can occur.

[1]  Jih-Heng Li,et al.  New psychoactive substances in Taiwan: challenges and strategies. , 2020, Current opinion in psychiatry.

[2]  A. Riley,et al.  Abuse potential and toxicity of the synthetic cathinones (i.e., “Bath salts”) , 2020, Neuroscience & Biobehavioral Reviews.

[3]  Lian-Yu Chen,et al.  Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department. , 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

[4]  F. Schifano,et al.  The clinical challenges of synthetic cathinones. , 2020, British journal of clinical pharmacology.

[5]  Eunyoung Han,et al.  Comparison of legislative management for new psychoactive substances control among Taiwan, South Korea, and Japan , 2020, The Kaohsiung journal of medical sciences.

[6]  Cheng-Chung Fang,et al.  Analytically confirmed 4-Methyl-N-ethylnorpentedrone (4-MEAP), a synthetic cathinone, in cases presenting to an emergency department , 2020, Clinical toxicology.

[7]  Lian-Yu Chen Psychiatric Profiles and Clinical Manifestations of Cathinone Users: Case Series of Analytically Confirmed Cathinone Use in Taiwan , 2019, Addiction & Addictive Disorders.

[8]  A. Helander,et al.  Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats , 2018, Clinical toxicology.

[9]  E. London,et al.  Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health , 2017, Front. Psychiatry.

[10]  C. Rabe,et al.  Synthetic cathinones in Southern Germany – characteristics of users, substance-patterns, co-ingestions, and complications , 2017, Clinical toxicology.

[11]  Heesun Chung,et al.  Comparison of illegal drug use pattern in Taiwan and Korea from 2006 to 2014 , 2016, Substance Abuse Treatment, Prevention, and Policy.

[12]  T. Sakamoto,et al.  A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan , 2016, The American journal of drug and alcohol abuse.

[13]  A. Helander,et al.  Intoxications involving MDPV in Sweden during 2010–2014: Results from the STRIDA project , 2015, Clinical toxicology.

[14]  F. Busardò,et al.  Mephedrone related fatalities: a review. , 2015, European review for medical and pharmacological sciences.

[15]  J. Palamar "Bath salt" use among a nationally representative sample of high school seniors in the United States. , 2015, The American journal on addictions.

[16]  L. Orsolini,et al.  Novel psychoactive substances of interest for psychiatry , 2015, World psychiatry : official journal of the World Psychiatric Association.

[17]  M. Liechti Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling. , 2015, Swiss medical weekly.

[18]  K. T. Wakabayashi,et al.  Effects of Social Interaction and Warm Ambient Temperature on Brain Hyperthermia Induced by the Designer Drugs Methylone and MDPV , 2015, Neuropsychopharmacology.

[19]  G. Hanson,et al.  Bath salts and synthetic cathinones: an emerging designer drug phenomenon. , 2014, Life sciences.

[20]  Wen-Ing Tsay,et al.  The trend of drug abuse in Taiwan during the years 1999 to 2011 , 2013 .

[21]  M. Casavant,et al.  A 9-state analysis of designer stimulant, "bath salt," hospital visits reported to poison control centers. , 2013, Annals of emergency medicine.

[22]  D. Touw,et al.  Clinical Toxicology and Management of Intoxications With Synthetic Cathinones (“Bath Salts”) , 2013, Journal of pharmacy practice.

[23]  M. Kane,et al.  Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA , 2013, Journal of neurochemistry.

[24]  F. Schifano,et al.  Suspected and Confirmed Fatalities Associated With Mephedrone (4-Methylmethcathinone, “Meow Meow”) in the United Kingdom , 2012, Journal of clinical psychopharmacology.

[25]  M. St-Onge,et al.  Seizures and Hyponatremia Related to Ethcathinone and Methylone Poisoning , 2011, Journal of Medical Toxicology.

[26]  J. Kelly,et al.  Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. , 2011, Drug testing and analysis.

[27]  Henry A Spiller,et al.  Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States , 2011, Clinical toxicology.

[28]  Mark Mitchelson,et al.  Mephedrone toxicity in a Scottish emergency department , 2010, Emergency Medicine Journal.

[29]  David W. Holt,et al.  Case series of individuals with analytically confirmed acute mephedrone toxicity , 2010, Clinical toxicology.

[30]  P. Dargan,et al.  Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. , 2010, QJM : monthly journal of the Association of Physicians.

[31]  J. O'Riordan,et al.  A harmless high? , 2010, The Lancet.

[32]  H. Persson,et al.  Poisoning severity score. Grading of acute poisoning. , 1998, Journal of toxicology. Clinical toxicology.

[33]  R. Glennon,et al.  Methcathinone (“cat”): An enantiomeric potency comparison , 1995, Pharmacology Biochemistry and Behavior.

[34]  M. Madion,et al.  Sudden retinal manifestations of intranasal cocaine and methamphetamine abuse. , 1992, American journal of ophthalmology.